Kirsch, I., Vignali, M., and Robins, H. (2015). T-cell receptor proﬁling in cancer. Mol. Oncol. 9, 2063–2070. https://doi.org/10.1016/j.molonc.2015.09.003 . https://www.ncbi.nlm.nih.gov/pubmed/26404496 . Kitano, S., Tsuji, T., Liu, C., Hirschhorn-Cymerman, D., Kyi, C., Mu, Z., Allison, J.P., Gnjatic, S., Yuan, J.D., and Wolchok, J.D. (2013). Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in fouradvanced melanoma patients. Cancer Immunol. Res. 1, 235–244. https://doi. org/10.1158/2326-6066.CIR-13-0068 .https://www.ncbi.nlm.nih.gov/pubmed/ 24396833 . Koboldt, D.C., Zhang, Q., Larson, D.E., Shen, D., McLellan, M.D., Lin, L., Miller, C.A., Mardis, E.R., Ding, L., and Wilson, R.K. (2012). VarScan 2: somatic mu-tation and copy number alteration discovery in cancer by exome sequencing.Genome Res. 22, 568–576.